# Xiao Hongxing

> Xiao Hongxing is a Series A investor backing Biopharma and Health Care. See 1 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: Angel Investor
- Location: Guangzhou, China
- Total investments: 1
- Last investment: Jul 2026
- Lead investor: 0%
- Last updated: Aug 2026

Xiao Hongxing is a Series A investor in Guangzhou focused on Biopharma and Health Care. Xiao Hongxing is the Chairman of Guangzhou Guanghe Technology Co., Ltd. (Delton Technology), a prominent dual-listed printed circuit board manufacturer based in Guangzhou.

## Contacts

5 contacts available for Xiao Hongxing: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/xiao-hongxing?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biopharma | 1 | 100% |
| Health Care | 1 | 100% |
| Biotechnology | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| MingCeler | MingCeler is a Bio-Island Laboratory incubation enterprise focused on developing TurboMice™ tetraploid compensation technology. It provides high-end, fast, and excellent model biological technology services and resources for pharmaceutical companies, vaccine companies, universities, research institutes, hospitals, and other life and health-relatedresearch teams. |  | Series A | Jul 13, 2026 | https://www.mingceler.com |

1 of 1 investments shown.

## Co-investors
- [Haikou Gangyin](https://shizune.co/investors/profile/haikou-gangyin) — VC Fund, 1 deal together
- [Synergetic Innovation Fund Management](https://shizune.co/investors/profile/synergetic-innovation-fund-management) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund

## Featured in investor lists
- [Biotechnology Angel Investors in China](https://shizune.co/investors/biotechnology-angel-investors-china)
- [Biotech Angel Investors in China](https://shizune.co/investors/biotech-angel-investors-china)

## FAQ

### What does Xiao Hongxing invest in?

Xiao Hongxing invests primarily in Biopharma, Health Care and Biotechnology startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Xiao Hongxing?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Xiao Hongxing last invest?

The most recent investment recorded for Xiao Hongxing closed in Jul 2026. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co